Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing
Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
Low-dose Glucocorticoid Vasculitis Induction Study
|6||Active, not recruiting||
Rituximab Vasculitis Maintenance Study
† Study has passed its completion date and status has not been verified in more than two years.